Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP215206.RA8TnmsdV3RNrtQQVQKOBIEJBn2j3HDB4XxxuEylMSZTA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP215206.RA8TnmsdV3RNrtQQVQKOBIEJBn2j3HDB4XxxuEylMSZTA130_assertion type Assertion NP215206.RA8TnmsdV3RNrtQQVQKOBIEJBn2j3HDB4XxxuEylMSZTA130_head.
- NP215206.RA8TnmsdV3RNrtQQVQKOBIEJBn2j3HDB4XxxuEylMSZTA130_assertion description "[As many of these evaluations are obscured by a heterogeneity of treatments, the current study aimed to evaluate the incidence and prognostic value of the promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT in HNSCC treated solely by radiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP215206.RA8TnmsdV3RNrtQQVQKOBIEJBn2j3HDB4XxxuEylMSZTA130_provenance.
- NP215206.RA8TnmsdV3RNrtQQVQKOBIEJBn2j3HDB4XxxuEylMSZTA130_assertion evidence source_evidence_literature NP215206.RA8TnmsdV3RNrtQQVQKOBIEJBn2j3HDB4XxxuEylMSZTA130_provenance.
- NP215206.RA8TnmsdV3RNrtQQVQKOBIEJBn2j3HDB4XxxuEylMSZTA130_assertion SIO_000772 19148529 NP215206.RA8TnmsdV3RNrtQQVQKOBIEJBn2j3HDB4XxxuEylMSZTA130_provenance.
- NP215206.RA8TnmsdV3RNrtQQVQKOBIEJBn2j3HDB4XxxuEylMSZTA130_assertion wasDerivedFrom befree-20140225 NP215206.RA8TnmsdV3RNrtQQVQKOBIEJBn2j3HDB4XxxuEylMSZTA130_provenance.
- NP215206.RA8TnmsdV3RNrtQQVQKOBIEJBn2j3HDB4XxxuEylMSZTA130_assertion wasGeneratedBy ECO_0000203 NP215206.RA8TnmsdV3RNrtQQVQKOBIEJBn2j3HDB4XxxuEylMSZTA130_provenance.